Entering strategic R&D partnerships

Collaborate with us

Grünenthal’s strategic R&D activities are focused on pain, epilepsy, pruritus and neurodegenerative disorders - areas of high unmet medical need.

We are committed to entering long-term strategic R&D partnerships to tap into the best science around the world. As a deeply experienced company with a specialisation in the therapeutic area of pain, we share our capabilities with partners at every stage in the development process – from target identification all the way through to regulatory approval and commercialisation. Our partnerships bring together leading players from academia and industry to seek new ways of improving quality of life for patients.

Our dedicated External Innovation team takes an agile approach to searching for and evaluating external innovation projects and partnership opportunities. At all times, we maintain a strong focus on true innovation to drive progress towards a world free of pain.